Loading…

Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up

Background Allergic rhinitis (AR) is one of the most common chronic diseases worldwide. There are limited prospective long‐term data regarding persistency and remission of AR. The objective of this study was to investigate the natural course of pollen‐induced AR (pollen‐AR) over 20 years, from child...

Full description

Saved in:
Bibliographic Details
Published in:Allergy (Copenhagen) 2024-04, Vol.79 (4), p.884-893
Main Authors: Lindqvist, Magnus, Leth‐Møller, Katja Biering, Linneberg, Allan, Kull, Inger, Bergström, Anna, Georgellis, Antonios, Borres, Magnus P., Ekebom, Agneta, Hage, Marianne, Melén, Erik, Westman, Marit
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43
cites cdi_FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43
container_end_page 893
container_issue 4
container_start_page 884
container_title Allergy (Copenhagen)
container_volume 79
creator Lindqvist, Magnus
Leth‐Møller, Katja Biering
Linneberg, Allan
Kull, Inger
Bergström, Anna
Georgellis, Antonios
Borres, Magnus P.
Ekebom, Agneta
Hage, Marianne
Melén, Erik
Westman, Marit
description Background Allergic rhinitis (AR) is one of the most common chronic diseases worldwide. There are limited prospective long‐term data regarding persistency and remission of AR. The objective of this study was to investigate the natural course of pollen‐induced AR (pollen‐AR) over 20 years, from childhood into early adulthood. Methods Data from 1137 subjects in the Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort (BAMSE) with a completed questionnaire regarding symptoms, asthma, treatment with allergen immunotherapy (AIT) and results of allergen‐specific IgE for inhalant allergens at 4, 8, 16 and 24 years were analyzed. Pollen‐AR was defined as sneezing, runny, itchy or blocked nose; and itchy or watery eyes when exposed to birch and/or grass pollen in combination with allergen‐specific IgE ≥0.35kUA/L to birch and/or grass. Results Approximately 75% of children with pollen‐AR at 4 or 8 years had persistent disease up to 24 years, and 30% developed asthma. The probability of persistency was high already at low levels of pollen‐specific IgE. The highest rate of remission from pollen‐AR was seen between 16 and 24 years (21.5%); however, the majority remained sensitized. This period was also when pollen‐specific IgE‐levels stopped increasing and the average estimated annual incidence of pollen‐AR decreased from 1.5% to 0.8% per year. Conclusion Children with pollen‐AR are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Our findings underline the close cross‐sectional and longitudinal relationship between sensitization, AR and asthma. 1137 subjects in the BAMSE birth cohort were followed prospectively over 20 years. Children with pollen induced allergic rhinitis are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Abbreviations: AR, allergic rhinitis; BAMSE, Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort; sIgE, specific immunoglobulin E.
doi_str_mv 10.1111/all.15927
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_830608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3020340088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43</originalsourceid><addsrcrecordid>eNqFks-O0zAQxiMEYsvCgRdAlriAILtjO05sbtXyV6rgAlwtJ5m0Xtw42LWq3ngEnpEnwaXdRUKq8MUe-_d9mvFMUTymcEHzujTOXVChWHOnmFGuZKmUEneLGVAQZSW4PCsexHgNAA1TcL84442idQ31rFh-NJsUjCOdTyEi8QOZvHM4_vrx04596rAn2R7D0nYkrOxoNzaSIfg16VbW9Svve7LxxPTJbfbBKzInDLJ6hyaQIXv5LUnTw-LeYFzER8f9vPjy9s3nq_fl4tO7D1fzRdmJSjVl3zJDsWZD1cm-GTijhkJnOmoqFFUzYFtBD4iVaGpFJWsl560QqAZmMD_y86I8-MYtTqnVU7BrE3baG6uPV9_yCbXkUIPMvDrJT8H3f0U3QioqkMApzdqXJ7Wv7de59mGpU9KC05qyjL_4Pz6GdebZnn52oHMW3xPGjV7b2KFzZkSfomZSCsFVXe9rfvoPep2bOeZv1hwY8ApA7it9fqC64GMMONwmQEHvx0jnPus_Y5TZJ0fH1K6xvyVv5iYDlwdgax3uTjvp-WJxsPwNlfPVGA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3020340088</pqid></control><display><type>article</type><title>Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up</title><source>Wiley</source><creator>Lindqvist, Magnus ; Leth‐Møller, Katja Biering ; Linneberg, Allan ; Kull, Inger ; Bergström, Anna ; Georgellis, Antonios ; Borres, Magnus P. ; Ekebom, Agneta ; Hage, Marianne ; Melén, Erik ; Westman, Marit</creator><creatorcontrib>Lindqvist, Magnus ; Leth‐Møller, Katja Biering ; Linneberg, Allan ; Kull, Inger ; Bergström, Anna ; Georgellis, Antonios ; Borres, Magnus P. ; Ekebom, Agneta ; Hage, Marianne ; Melén, Erik ; Westman, Marit</creatorcontrib><description>Background Allergic rhinitis (AR) is one of the most common chronic diseases worldwide. There are limited prospective long‐term data regarding persistency and remission of AR. The objective of this study was to investigate the natural course of pollen‐induced AR (pollen‐AR) over 20 years, from childhood into early adulthood. Methods Data from 1137 subjects in the Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort (BAMSE) with a completed questionnaire regarding symptoms, asthma, treatment with allergen immunotherapy (AIT) and results of allergen‐specific IgE for inhalant allergens at 4, 8, 16 and 24 years were analyzed. Pollen‐AR was defined as sneezing, runny, itchy or blocked nose; and itchy or watery eyes when exposed to birch and/or grass pollen in combination with allergen‐specific IgE ≥0.35kUA/L to birch and/or grass. Results Approximately 75% of children with pollen‐AR at 4 or 8 years had persistent disease up to 24 years, and 30% developed asthma. The probability of persistency was high already at low levels of pollen‐specific IgE. The highest rate of remission from pollen‐AR was seen between 16 and 24 years (21.5%); however, the majority remained sensitized. This period was also when pollen‐specific IgE‐levels stopped increasing and the average estimated annual incidence of pollen‐AR decreased from 1.5% to 0.8% per year. Conclusion Children with pollen‐AR are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Our findings underline the close cross‐sectional and longitudinal relationship between sensitization, AR and asthma. 1137 subjects in the BAMSE birth cohort were followed prospectively over 20 years. Children with pollen induced allergic rhinitis are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Abbreviations: AR, allergic rhinitis; BAMSE, Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort; sIgE, specific immunoglobulin E.</description><identifier>ISSN: 0105-4538</identifier><identifier>ISSN: 1398-9995</identifier><identifier>EISSN: 1398-9995</identifier><identifier>DOI: 10.1111/all.15927</identifier><identifier>PMID: 37916606</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>Allergens ; Allergic rhinitis ; Allergies ; Asthma ; BAMSE ; Childhood ; Children ; Chronic illnesses ; Epidemiology ; Hay fever ; IgE ; Immunoglobulin E ; Immunotherapy ; Man and the environment ; Medical treatment ; Medicin och hälsovetenskap ; Naturmiljö och människan ; Pollen ; pollen allergy ; Remission ; Remission (Medicine) ; Rhinitis</subject><ispartof>Allergy (Copenhagen), 2024-04, Vol.79 (4), p.884-893</ispartof><rights>2023 The Authors. published by European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</rights><rights>2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley &amp; Sons Ltd.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43</citedby><cites>FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43</cites><orcidid>0000-0002-9045-2304 ; 0000-0002-7981-6314 ; 0000-0002-1624-9789 ; 0000-0002-0994-0184 ; 0000-0001-6096-3771 ; 0009-0006-5431-7494 ; 0000-0002-0657-1512 ; 0000-0003-0343-9863 ; 0000-0003-3091-1596 ; 0000-0002-8248-0663 ; 0000-0003-0041-4249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37916606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:nrm:diva-5322$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-531612$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:154080311$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindqvist, Magnus</creatorcontrib><creatorcontrib>Leth‐Møller, Katja Biering</creatorcontrib><creatorcontrib>Linneberg, Allan</creatorcontrib><creatorcontrib>Kull, Inger</creatorcontrib><creatorcontrib>Bergström, Anna</creatorcontrib><creatorcontrib>Georgellis, Antonios</creatorcontrib><creatorcontrib>Borres, Magnus P.</creatorcontrib><creatorcontrib>Ekebom, Agneta</creatorcontrib><creatorcontrib>Hage, Marianne</creatorcontrib><creatorcontrib>Melén, Erik</creatorcontrib><creatorcontrib>Westman, Marit</creatorcontrib><title>Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up</title><title>Allergy (Copenhagen)</title><addtitle>Allergy</addtitle><description>Background Allergic rhinitis (AR) is one of the most common chronic diseases worldwide. There are limited prospective long‐term data regarding persistency and remission of AR. The objective of this study was to investigate the natural course of pollen‐induced AR (pollen‐AR) over 20 years, from childhood into early adulthood. Methods Data from 1137 subjects in the Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort (BAMSE) with a completed questionnaire regarding symptoms, asthma, treatment with allergen immunotherapy (AIT) and results of allergen‐specific IgE for inhalant allergens at 4, 8, 16 and 24 years were analyzed. Pollen‐AR was defined as sneezing, runny, itchy or blocked nose; and itchy or watery eyes when exposed to birch and/or grass pollen in combination with allergen‐specific IgE ≥0.35kUA/L to birch and/or grass. Results Approximately 75% of children with pollen‐AR at 4 or 8 years had persistent disease up to 24 years, and 30% developed asthma. The probability of persistency was high already at low levels of pollen‐specific IgE. The highest rate of remission from pollen‐AR was seen between 16 and 24 years (21.5%); however, the majority remained sensitized. This period was also when pollen‐specific IgE‐levels stopped increasing and the average estimated annual incidence of pollen‐AR decreased from 1.5% to 0.8% per year. Conclusion Children with pollen‐AR are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Our findings underline the close cross‐sectional and longitudinal relationship between sensitization, AR and asthma. 1137 subjects in the BAMSE birth cohort were followed prospectively over 20 years. Children with pollen induced allergic rhinitis are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Abbreviations: AR, allergic rhinitis; BAMSE, Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort; sIgE, specific immunoglobulin E.</description><subject>Allergens</subject><subject>Allergic rhinitis</subject><subject>Allergies</subject><subject>Asthma</subject><subject>BAMSE</subject><subject>Childhood</subject><subject>Children</subject><subject>Chronic illnesses</subject><subject>Epidemiology</subject><subject>Hay fever</subject><subject>IgE</subject><subject>Immunoglobulin E</subject><subject>Immunotherapy</subject><subject>Man and the environment</subject><subject>Medical treatment</subject><subject>Medicin och hälsovetenskap</subject><subject>Naturmiljö och människan</subject><subject>Pollen</subject><subject>pollen allergy</subject><subject>Remission</subject><subject>Remission (Medicine)</subject><subject>Rhinitis</subject><issn>0105-4538</issn><issn>1398-9995</issn><issn>1398-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqFks-O0zAQxiMEYsvCgRdAlriAILtjO05sbtXyV6rgAlwtJ5m0Xtw42LWq3ngEnpEnwaXdRUKq8MUe-_d9mvFMUTymcEHzujTOXVChWHOnmFGuZKmUEneLGVAQZSW4PCsexHgNAA1TcL84442idQ31rFh-NJsUjCOdTyEi8QOZvHM4_vrx04596rAn2R7D0nYkrOxoNzaSIfg16VbW9Svve7LxxPTJbfbBKzInDLJ6hyaQIXv5LUnTw-LeYFzER8f9vPjy9s3nq_fl4tO7D1fzRdmJSjVl3zJDsWZD1cm-GTijhkJnOmoqFFUzYFtBD4iVaGpFJWsl560QqAZmMD_y86I8-MYtTqnVU7BrE3baG6uPV9_yCbXkUIPMvDrJT8H3f0U3QioqkMApzdqXJ7Wv7de59mGpU9KC05qyjL_4Pz6GdebZnn52oHMW3xPGjV7b2KFzZkSfomZSCsFVXe9rfvoPep2bOeZv1hwY8ApA7it9fqC64GMMONwmQEHvx0jnPus_Y5TZJ0fH1K6xvyVv5iYDlwdgax3uTjvp-WJxsPwNlfPVGA</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Lindqvist, Magnus</creator><creator>Leth‐Møller, Katja Biering</creator><creator>Linneberg, Allan</creator><creator>Kull, Inger</creator><creator>Bergström, Anna</creator><creator>Georgellis, Antonios</creator><creator>Borres, Magnus P.</creator><creator>Ekebom, Agneta</creator><creator>Hage, Marianne</creator><creator>Melén, Erik</creator><creator>Westman, Marit</creator><general>Blackwell Publishing Ltd</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>ACNBI</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0002-9045-2304</orcidid><orcidid>https://orcid.org/0000-0002-7981-6314</orcidid><orcidid>https://orcid.org/0000-0002-1624-9789</orcidid><orcidid>https://orcid.org/0000-0002-0994-0184</orcidid><orcidid>https://orcid.org/0000-0001-6096-3771</orcidid><orcidid>https://orcid.org/0009-0006-5431-7494</orcidid><orcidid>https://orcid.org/0000-0002-0657-1512</orcidid><orcidid>https://orcid.org/0000-0003-0343-9863</orcidid><orcidid>https://orcid.org/0000-0003-3091-1596</orcidid><orcidid>https://orcid.org/0000-0002-8248-0663</orcidid><orcidid>https://orcid.org/0000-0003-0041-4249</orcidid></search><sort><creationdate>202404</creationdate><title>Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up</title><author>Lindqvist, Magnus ; Leth‐Møller, Katja Biering ; Linneberg, Allan ; Kull, Inger ; Bergström, Anna ; Georgellis, Antonios ; Borres, Magnus P. ; Ekebom, Agneta ; Hage, Marianne ; Melén, Erik ; Westman, Marit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Allergens</topic><topic>Allergic rhinitis</topic><topic>Allergies</topic><topic>Asthma</topic><topic>BAMSE</topic><topic>Childhood</topic><topic>Children</topic><topic>Chronic illnesses</topic><topic>Epidemiology</topic><topic>Hay fever</topic><topic>IgE</topic><topic>Immunoglobulin E</topic><topic>Immunotherapy</topic><topic>Man and the environment</topic><topic>Medical treatment</topic><topic>Medicin och hälsovetenskap</topic><topic>Naturmiljö och människan</topic><topic>Pollen</topic><topic>pollen allergy</topic><topic>Remission</topic><topic>Remission (Medicine)</topic><topic>Rhinitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindqvist, Magnus</creatorcontrib><creatorcontrib>Leth‐Møller, Katja Biering</creatorcontrib><creatorcontrib>Linneberg, Allan</creatorcontrib><creatorcontrib>Kull, Inger</creatorcontrib><creatorcontrib>Bergström, Anna</creatorcontrib><creatorcontrib>Georgellis, Antonios</creatorcontrib><creatorcontrib>Borres, Magnus P.</creatorcontrib><creatorcontrib>Ekebom, Agneta</creatorcontrib><creatorcontrib>Hage, Marianne</creatorcontrib><creatorcontrib>Melén, Erik</creatorcontrib><creatorcontrib>Westman, Marit</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley-Blackwell Free Backfiles(OpenAccess)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><jtitle>Allergy (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindqvist, Magnus</au><au>Leth‐Møller, Katja Biering</au><au>Linneberg, Allan</au><au>Kull, Inger</au><au>Bergström, Anna</au><au>Georgellis, Antonios</au><au>Borres, Magnus P.</au><au>Ekebom, Agneta</au><au>Hage, Marianne</au><au>Melén, Erik</au><au>Westman, Marit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up</atitle><jtitle>Allergy (Copenhagen)</jtitle><addtitle>Allergy</addtitle><date>2024-04</date><risdate>2024</risdate><volume>79</volume><issue>4</issue><spage>884</spage><epage>893</epage><pages>884-893</pages><issn>0105-4538</issn><issn>1398-9995</issn><eissn>1398-9995</eissn><abstract>Background Allergic rhinitis (AR) is one of the most common chronic diseases worldwide. There are limited prospective long‐term data regarding persistency and remission of AR. The objective of this study was to investigate the natural course of pollen‐induced AR (pollen‐AR) over 20 years, from childhood into early adulthood. Methods Data from 1137 subjects in the Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort (BAMSE) with a completed questionnaire regarding symptoms, asthma, treatment with allergen immunotherapy (AIT) and results of allergen‐specific IgE for inhalant allergens at 4, 8, 16 and 24 years were analyzed. Pollen‐AR was defined as sneezing, runny, itchy or blocked nose; and itchy or watery eyes when exposed to birch and/or grass pollen in combination with allergen‐specific IgE ≥0.35kUA/L to birch and/or grass. Results Approximately 75% of children with pollen‐AR at 4 or 8 years had persistent disease up to 24 years, and 30% developed asthma. The probability of persistency was high already at low levels of pollen‐specific IgE. The highest rate of remission from pollen‐AR was seen between 16 and 24 years (21.5%); however, the majority remained sensitized. This period was also when pollen‐specific IgE‐levels stopped increasing and the average estimated annual incidence of pollen‐AR decreased from 1.5% to 0.8% per year. Conclusion Children with pollen‐AR are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Our findings underline the close cross‐sectional and longitudinal relationship between sensitization, AR and asthma. 1137 subjects in the BAMSE birth cohort were followed prospectively over 20 years. Children with pollen induced allergic rhinitis are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Abbreviations: AR, allergic rhinitis; BAMSE, Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort; sIgE, specific immunoglobulin E.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>37916606</pmid><doi>10.1111/all.15927</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-9045-2304</orcidid><orcidid>https://orcid.org/0000-0002-7981-6314</orcidid><orcidid>https://orcid.org/0000-0002-1624-9789</orcidid><orcidid>https://orcid.org/0000-0002-0994-0184</orcidid><orcidid>https://orcid.org/0000-0001-6096-3771</orcidid><orcidid>https://orcid.org/0009-0006-5431-7494</orcidid><orcidid>https://orcid.org/0000-0002-0657-1512</orcidid><orcidid>https://orcid.org/0000-0003-0343-9863</orcidid><orcidid>https://orcid.org/0000-0003-3091-1596</orcidid><orcidid>https://orcid.org/0000-0002-8248-0663</orcidid><orcidid>https://orcid.org/0000-0003-0041-4249</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0105-4538
ispartof Allergy (Copenhagen), 2024-04, Vol.79 (4), p.884-893
issn 0105-4538
1398-9995
1398-9995
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_830608
source Wiley
subjects Allergens
Allergic rhinitis
Allergies
Asthma
BAMSE
Childhood
Children
Chronic illnesses
Epidemiology
Hay fever
IgE
Immunoglobulin E
Immunotherapy
Man and the environment
Medical treatment
Medicin och hälsovetenskap
Naturmiljö och människan
Pollen
pollen allergy
Remission
Remission (Medicine)
Rhinitis
title Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A00%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Natural%20course%20of%20pollen%E2%80%90induced%20allergic%20rhinitis%20from%20childhood%20to%20adulthood:%20A%2020%E2%80%90year%20follow%20up&rft.jtitle=Allergy%20(Copenhagen)&rft.au=Lindqvist,%20Magnus&rft.date=2024-04&rft.volume=79&rft.issue=4&rft.spage=884&rft.epage=893&rft.pages=884-893&rft.issn=0105-4538&rft.eissn=1398-9995&rft_id=info:doi/10.1111/all.15927&rft_dat=%3Cproquest_swepu%3E3020340088%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5497-db2a1e62f4c8d7f321a10cac1a4e547feb40d0ee45769182b833b55e9f2aeeb43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3020340088&rft_id=info:pmid/37916606&rfr_iscdi=true